3D Imaging Drug Design and Development — FDA Facility Profile
3D Imaging Drug Design and Development is an FDA-registered facility (FEI 3009143510) located in Little Rock, AR, US. Registered operations: POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION. RegDataLab tracks 3 FDA inspections and 1 compliance action at this facility.
Facility Details
- Location
- Little Rock, AR (US)
- Registration Expires
- December 31, 2026
- Operations
- POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION
- Source
- decrs